TEST INSTRUCTIONS

Read the article. The test for this nursing continuing professional development (NCPD) activity is to be taken online at www.nursingcenter.com/CE/JHPN. Tests can no longer be mailed or faxed. You'll need to create an account (it's free!) and log in to access My Planner before taking online tests. Your planner will keep track of all your Lippincott Professional Development online NCPD activities for you. There's only one correct answer for each question. A passing score for this test is 7 correct answers. If you pass, you can print your certificate of earned contact hours and access the answer key. If you fail, you have the option of taking the test again at no additional cost. For questions, contact Lippincott Professional Development: 1-800-787-8985. Registration deadline is June 5, 2026.

PROVIDER ACCREDITATION

Lippincott Professional Development will award 1.5 contact hours for this nursing continuing professional development activity.

Lippincott Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 1.5 contact hours.

Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia, Georgia, West Virginia, New Mexico, South Carolina & Florida, CE Broker #50-1223. Your certificate is valid in all states.

Payment: The registration fee for this test is $17.95.

LEARNING OUTCOME: Seventy-five percent of participants will demonstrate knowledge of a study repeating an earlier study assessing symptom and quality of life concerns of patients with non-small cell lung cancer by achieving a minimum score of 70% on the outcomes-based posttest.

LEARNING OBJECTIVES: After completing this continuing professional development activity, the participant will apply knowledge gained to:

1. Recognize the background information the authors considered when planning their study of the symptom and quality of life concerns of patients with non-small cell lung cancer.

2. Identify the diagnosis and treatment of the patients whose charts the authors audited for their study of the symptom and quality of life concerns of patients with non-small cell lung cancer.

3. Select the results of the authors’ study of the symptom and quality of life concerns of patients with non-small cell lung cancer.

Recently, research has indicated that which of the following types of adjuvant treatment for non-small cell lung cancer (NSCLC) has shown statistically significant improvement in disease-free survival? VEGF inhibitors PDL1 inhibitors biologic agents Based on the results of the IMpower010 randomized phase III trial of therapy for patients with stage IB-IIIA NSCLC after surgical resection and adjuvant chemotherapy, which of the following drugs is the recommended treatment? atezolizumab bevacizumab pembrolizumab Of the patients whose charts were audited for the authors’ study, the largest group had NSCLC in which stage? II III IV The most common treatment the patients included in the study had received was surgery. chemotherapy. radiation therapy. The most common symptoms the patients reported was pain. cough. fatigue. Of the included patients, 63% received which of the following supportive care referrals? none nutrition social work Of the study subjects, 68% had such an unscheduled medical encounter, with which of the following as the most common reason for the visit? dyspnea nausea pain Of the study subjects, 20% had an unscheduled hospital admission, with which of the following as the most common reason for hospitalization? constipation dyspnea pain The results of the study indicated that a low percentage of the patients remained at full code status. a low percentage of the patients had designated a proxy decision maker. no additional patients had completed advance directives at 6-month follow-up. The authors concluded that the outcomes of unscheduled visits and admissions in their study indicated that high resource utilization is a reflection of inadequate clinic availability. misunderstanding of protocols. the lack of a palliative care focus.